When using ultrasound to follow up on suspicious breast masses in patients who just got a second dose of a COVID-19 vaccine, it may be wise to postpone scans to between 12 and 16 weeks to reduce unnecessary biopsies, according to research published in the American Journal of Roentgenology. Read more
